Symptomatic vitreous floaters

被引:0
作者
Olate-Perez, Alvaro [1 ,2 ]
Lutz, Alejandro [1 ]
机构
[1] Clin Las Condes, Dept Oftalmol, Unidad Retina, Santiago, Chile
[2] Hosp Salvador, Serv Oftalmol, Unidad Retina, Santiago, Chile
来源
REVISTA MEDICA CLINICA LAS CONDES | 2023年 / 34卷 / 05期
关键词
Floaters; Myodesopsia; Vitreous; Posterior Vitreous Detachment; PARS-PLANA VITRECTOMY; SUTURELESS VITRECTOMY; YAG VITREOLYSIS; RETINAL BREAK; 20-GAUGE; DETACHMENT; SAFETY; ENDOPHTHALMITIS; COMPLICATIONS; OCRIPLASMIN;
D O I
10.1016/j.rmclc.2023.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vitreous humor is a gel composed of extracellular matrix and water. It is one of the elements responsible for maintaining the transparency of the intraocular cavity, and thus, the transmission of light to the retina without interference. This transparency can be affected by physiological changes in its structure such as aging or myopia (primary etiology), as well as external or secondary causes (hemorrhage, increased cellularity or crystal deposits), causing vitreous opacities. The clinical expression of these opacities is the visualization of mobile spots in the visual field (myodesopsia or entopsia). The primary causes can usually be managed conservatively, if they do not involve retinal involvement, but in some cases they can considerably affect the quality of life. This can be assessed by objective methods such as: ultrasound, optical coherence tomography or laser scanning ophthalmoscopy, or subjective such as: quality of life or contrast sensitivity questionnaires. In these cases, interventional management with Nd:YAG laser therapy or vitrectomy can be considered.
引用
收藏
页码:327 / 334
页数:8
相关论文
共 40 条
[11]   Posterior Vitreous Detachment: Evolution and Complications of Its Early Stages [J].
Johnson, Mark W. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (03) :371-382
[12]   Asteroid hyalosis: pathogenesis and prospects for prevention [J].
Kador, P. F. ;
Wyman, M. .
EYE, 2008, 22 (10) :1278-1285
[13]   Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview [J].
Katsanos, Andreas ;
Tsaldari, Nikoleta ;
Gorgoli, Konstantina ;
Lalos, Fotios ;
Stefaniotou, Maria ;
Asproudis, Ioannis .
ADVANCES IN THERAPY, 2020, 37 (04) :1319-1327
[14]   Pharmacologic Vitreolysis with Ocriplasmin: Rationale for Use and Therapeutic Potential in Vitreo-Retinal Disorders [J].
Khoshnevis, Matin ;
Sebag, J. .
BIODRUGS, 2015, 29 (02) :103-112
[15]   Incidence of endophthalmitis after 20- and 25-gauge vitrectomy [J].
Kunimoto, Derek Y. ;
Kaiser, Richard S. .
OPHTHALMOLOGY, 2007, 114 (12) :2133-2137
[16]   Efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous floaters: A randomized controlled trial [J].
Ludwig, Gustavo D. ;
Gemelli, Henrique ;
Nunes, Guilherme M. ;
Serracarbassa, Pedro D. ;
Zanotele, Margara .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (03) :909-914
[17]   Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters [J].
Luo, Jihan ;
An, Xiaoju ;
Kuang, Yi .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2018, 46 (11) :4465-4471
[18]   Ultrasound-Based Quantification of Vitreous Floaters Correlates with Contrast Sensitivity and Quality of Life [J].
Mamou, Jonathan ;
Wa, Christianne A. ;
Yee, Kenneth M. P. ;
Silverman, Ronald H. ;
Ketterling, Jeffrey A. ;
Sadun, Alfredo A. ;
Sebag, J. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (03) :1611-1617
[19]   SAFETY, EFFICACY, AND QUALITY OF LIFE FOLLOWING SUTURELESS VITRECTOMY FOR SYMPTOMATIC VITREOUS FLOATERS [J].
Mason, John O., III ;
Neimkin, Michael G. ;
Mason, John O. ;
Friedman, Duncan A. ;
Feist, Richard M. ;
Thomley, Martin L. ;
Albert, Michael A. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (06) :1055-1061
[20]   Vitreous floaters: Etiology, diagnostics, and management [J].
Milston, Rebecca ;
Madigan, Michele C. ;
Sebag, J. .
SURVEY OF OPHTHALMOLOGY, 2016, 61 (02) :211-227